BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1362 related articles for article (PubMed ID: 32770825)

  • 1. Bacterial co-infections with SARS-CoV-2.
    Mirzaei R; Goodarzi P; Asadi M; Soltani A; Aljanabi HAA; Jeda AS; Dashtbin S; Jalalifar S; Mohammadzadeh R; Teimoori A; Tari K; Salari M; Ghiasvand S; Kazemi S; Yousefimashouf R; Keyvani H; Karampoor S
    IUBMB Life; 2020 Oct; 72(10):2097-2111. PubMed ID: 32770825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The microbial coinfection in COVID-19.
    Chen X; Liao B; Cheng L; Peng X; Xu X; Li Y; Hu T; Li J; Zhou X; Ren B
    Appl Microbiol Biotechnol; 2020 Sep; 104(18):7777-7785. PubMed ID: 32780290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting.
    Hughes S; Troise O; Donaldson H; Mughal N; Moore LSP
    Clin Microbiol Infect; 2020 Oct; 26(10):1395-1399. PubMed ID: 32603803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial Epidemiology and Antimicrobial Resistance Profiles in Children Reported by the ISPED Program in China, 2016 to 2020.
    Fu P; Xu H; Jing C; Deng J; Wang H; Hua C; Chen Y; Chen X; Zhang T; Zhang H; Chen Y; Yang J; Lin A; Wang S; Cao Q; Wang X; Deng H; Cao S; Hao J; Gao W; Huang Y; Yu H; Wang C
    Microbiol Spectr; 2021 Dec; 9(3):e0028321. PubMed ID: 34730410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction Between SARS-CoV-2 and Pathogenic Bacteria.
    Fazel P; Sedighian H; Behzadi E; Kachuei R; Imani Fooladi AA
    Curr Microbiol; 2023 May; 80(7):223. PubMed ID: 37222840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of bacterial co-infections of the respiratory tract in COVID-19 patients admitted to ICU.
    Sharifipour E; Shams S; Esmkhani M; Khodadadi J; Fotouhi-Ardakani R; Koohpaei A; Doosti Z; Ej Golzari S
    BMC Infect Dis; 2020 Sep; 20(1):646. PubMed ID: 32873235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interface between COVID-19 and bacterial healthcare-associated infections.
    O'Toole RF
    Clin Microbiol Infect; 2021 Dec; 27(12):1772-1776. PubMed ID: 34111586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommendations for antibacterial therapy in adults with COVID-19 - an evidence based guideline.
    Sieswerda E; de Boer MGJ; Bonten MMJ; Boersma WG; Jonkers RE; Aleva RM; Kullberg BJ; Schouten JA; van de Garde EMW; Verheij TJ; van der Eerden MM; Prins JM; Wiersinga WJ
    Clin Microbiol Infect; 2021 Jan; 27(1):61-66. PubMed ID: 33010444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coinfections with Other Respiratory Pathogens among Patients with COVID-19.
    Sreenath K; Batra P; Vinayaraj EV; Bhatia R; SaiKiran K; Singh V; Singh S; Verma N; Singh UB; Mohan A; Bhatnagar S; Trikha A; Guleria R; Chaudhry R
    Microbiol Spectr; 2021 Sep; 9(1):e0016321. PubMed ID: 34287033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents?
    Lai CC; Wang CY; Hsueh PR
    J Microbiol Immunol Infect; 2020 Aug; 53(4):505-512. PubMed ID: 32482366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of Streptococcus Pneumoniae Urinary Antigen Testing in Decreasing Mortality of COVID-19 Co-Infected Patients: A Clinical Investigation.
    Desai A; Santonocito OG; Caltagirone G; Kogan M; Ghetti F; Donadoni I; Porro F; Savevski V; Poretti D; Ciccarelli M; Martinelli Boneschi F; Voza A
    Medicina (Kaunas); 2020 Oct; 56(11):. PubMed ID: 33138045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship.
    Rothe K; Feihl S; Schneider J; Wallnöfer F; Wurst M; Lukas M; Treiber M; Lahmer T; Heim M; Dommasch M; Waschulzik B; Zink A; Querbach C; Busch DH; Schmid RM; Schneider G; Spinner CD
    Eur J Clin Microbiol Infect Dis; 2021 Apr; 40(4):859-869. PubMed ID: 33140176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial coinfections in COVID-19: an underestimated adversary.
    Fattorini L; Creti R; Palma C; Pantosti A; ;
    Ann Ist Super Sanita; 2020; 56(3):359-364. PubMed ID: 32959802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidrug-Resistant Infections and Outcome of Critically Ill Patients with Coronavirus Disease 2019: A Single Center Experience.
    Karruli A; Boccia F; Gagliardi M; Patauner F; Ursi MP; Sommese P; De Rosa R; Murino P; Ruocco G; Corcione A; Andini R; Zampino R; Durante-Mangoni E
    Microb Drug Resist; 2021 Sep; 27(9):1167-1175. PubMed ID: 33600262
    [No Abstract]   [Full Text] [Related]  

  • 15. State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia.
    Chong WH; Saha BK; Ananthakrishnan Ramani ; Chopra A
    Infection; 2021 Aug; 49(4):591-605. PubMed ID: 33709380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial Coinfections in Coronavirus Disease 2019.
    Westblade LF; Simon MS; Satlin MJ
    Trends Microbiol; 2021 Oct; 29(10):930-941. PubMed ID: 33934980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1997)].
    Ikemoto H; Ito C; Yoshida T; Watanabe K; Mori T; Ohno I; Okada S; Igari J; Arakawa M; Igarashi K; Oguri T; Okada M; Ozaki K; Terai T; Aoki N; Inoue H; Nakadate T; Kitamura N; Sekine O; Suzuki Y; Ando M; Suga M; Sato K; Nakata K; Kusano N
    Jpn J Antibiot; 1999 May; 52(5):353-97. PubMed ID: 10480048
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Sanchez A; Elliott EI; Wang P; Spichler-Moffarah A
    BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35232746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: results from a multicentre retrospective cohort study in The Netherlands.
    Karami Z; Knoop BT; Dofferhoff ASM; Blaauw MJT; Janssen NA; van Apeldoorn M; Kerckhoffs APM; van de Maat JS; Hoogerwerf JJ; Ten Oever J
    Infect Dis (Lond); 2021 Feb; 53(2):102-110. PubMed ID: 33103530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbial co-infections in COVID-19: Associated microbiota and underlying mechanisms of pathogenesis.
    Hoque MN; Akter S; Mishu ID; Islam MR; Rahman MS; Akhter M; Islam I; Hasan MM; Rahaman MM; Sultana M; Islam T; Hossain MA
    Microb Pathog; 2021 Jul; 156():104941. PubMed ID: 33962007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 69.